CNS Biomarkers

The term Biomarker can be defined as a measurable indicator of some biological state or condition. A biomarker can also be known as a biological biomarker.

CNS 2016 conference focuses on the development of CNS biomarkers for drugs and diagnostics from Cerebrospinal fluid and Blood, as well as imaging approaches. Scientific data, updates and case studies in neurological and neurodegenerative diseases will be presented on disease areas such as Alzheimer's and Parkinson's.

  • CNS drug development using biomarkers
  • Cerebrospinal fluid biomarkers
  • Neuroimaging enrichment biomarkers for CNS diseases
  • Biomarker Challenges in Rare Diseases
  • Technology case studies for CNS

Related Conference of CNS Biomarkers

August 29-31, 2017

15th European Neurology Congress

London, UK
August 29-31, 2017

6th World Congress on Addiction Disorder & Addiction Therapy

Prague, Czech Republic
August 31-September 01, 2017

3rdInternational Conference on Epilepsy and Treatment

Brussels, Belgium
October 16-17, 2017

17th Global Neuroscience Conference

Osaka, Japan
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
September 17-18, 2018

International Conference on Nervous System and Nerve Diseases

Philadelphia , USA
August 29-30, 2018

4th World Congress on Parkinsons and Huntington Disease

Zurich, Switzerland
September 10-12, 2018

4th International Conference on Spine and Spinal Disorders

Dublin, Ireland
September 17-18, 2018

4th World Congress on Epilepsy and Treatment

Bali, Indonesia
November 5-6, 2018

3rd International Conference on Spine and Spinal Disorder

San Franciso, USA

CNS Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in